Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting
Authors:
Open Access
- 26 September 2014
- journal article
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 78
Abstract
The purpose of this study was to explore the budget impact of dutasteride plus tamsulosin fixed-dose combination (DUT + TAM FDC) versus tamsulosin monotherapy, in the treatment of patients with benign prostatic hyperplasia (BPH) from the perspective of the Greek healthcare insurance system.Keywords
This publication has 27 references indexed in Scilit:
- Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trialCanadian Urological Association Journal, 2012
- Coste-efectividad de la combinación dutasterida y tamsulosina en el tratamiento de la hiperplasia benigna de próstata en EspañaActas Urológicas Españolas, 2011
- TURP in the new century: an analytical reappraisal in light of lasersCanadian Urological Association Journal, 2010
- Practical issues in handling data input and uncertainty in a budget impact analysisThe European Journal of Health Economics, 2010
- Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical managementInternational Journal Of Clinical Practice, 2008
- Urologic Diseases in America Project: Benign Prostatic HyperplasiaJournal of Urology, 2008
- Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact AnalysisValue in Health, 2007
- A taxonomy of model structures for economic evaluation of health technologiesHealth Economics, 2006
- Reoperation, Myocardial Infarction and Mortality after Transurethral and Open Prostatectomy: A Nation-Wide, Long-Term Analysis of 23,123 CasesEuropean Urology, 2005
- Economic Burden of Treated Benign Prostatic Hyperplasia in the United KingdomBritish Journal of Urology, 1993